cardiovascular-ncrna.de – advancing the understanding of ncRNA in the cardiovascular sytems

RESEARCH

Research Concept of TRR 267

The field of ncRNA is rapidly developing and probably most – if not all – key processes in cells are directly or indirectly controlled by these molecules. TRR 267 contributes to decipher the function of ncRNAs in the cardiovascular system thereby gaining important insights into the regulatory mechanisms of CV disease. This may – in the long-term – also open novel therapeutic avenues.

Section A

Regulation & mechanism of action of ncRNA in cardiovascular cells

Read More

Section B

Development & disease relevance of cardiovascular ncRNAs

Read More

CAREER

Career Support and Talent Search

We are seeking for highly motivated talents to join our research teams.

One important focus of the TRR 267 is the support of training and career support during all the different career stages. Our explicit commitment is the promotion of equal opportunities.

Early Career Support

To support researchers at all different career stages, each institution has established specific programs to offer training in research and general skills to undergraduate and Ph.D. students, postdocs, young investigators and PIs. This portfolio is further complemented by specific measures.

Read More

Gender Equality

The promotion of equal opportunities is an explicit commitment of all participating institutions of TRR 267. Our female scientists (and equally those of diverse gender) are encouraged in their scientific career and supported through specific measures within the project support.

Read More

Open Positions

Veterinary PhD Student

The Clinic and Polyclinic for Internal Medicine I of the Klinikum rechts der Isar of the Technical University of Munich is looking for a Veterinary PhD Student (m/f/d).

See All Job Advertisements

Research Projects

The research program aims on targeting specific, unmet medical needs, particularly the aspect of cardiac remodelling and heart failure, vascular remodelling and reparative/regenerative processes. An important basis for these studies are disease models in vitro and in vivo. TRR 267 includes 20 research projects under the leadership of 30 principal investigators.